Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents

被引:86
作者
Barrio, J
Ripoll, C
Bañares, R
Echenagusia, A
Catalina, MV
Camúñez, F
Simó, G
Santos, L
机构
[1] Hosp Gen Univ Gregorio Maranon, Dept Gastroenterol & Hepatol, Madrid 28007, Spain
[2] Hosp Gen Univ Gregorio Maranon, Dept Intervent Radiol, Madrid 28007, Spain
关键词
portal hypertension; transjugular intrahepatic portosystemic shunt; bare stent; PTFE-covered stent-grafts; TIPS dysfunction;
D O I
10.1016/j.ejrad.2004.10.007
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The aim was to compare the clinical and hemodynamic outcome between polytetrafluoroethylene (PTFE)-coated stent-grafts and bare stents in patients who required both elective and emergency transjugular intrahepatic portosystemic shunt (TIPS) placement due to portal hypertension related complications. Materials and methods: Retrospective analysis of all seventy patients with portal hypertension related complications who required TIPS placement in a referral hospital from September 1998 to May 2002 was done. Follow-up was extended until May 2003. PTFE-covered stent-grafts were used in the latter 20. Demographic variables, cirrhosis etiology and Child-Pugh class, indication of TIPS placement and clinical outcome were recorded. The following TIPS-related outcomes were registered: recurrent variceal bleeding and/or ascites, hepatic encephalopathy and mortality. Results: Baseline characteristics, portacaval gradient (PCG) after TIPS placement and at 1 month angiographic revision were similar in both groups. At 6 month follow-up, PCG was significantly lower in patients with stent-grafts (14.2 mmHg (5.6 mmHg) versus 7 mmHg (I mmHg), p < 0.001). Overall, there were no cases of clinically relevant TIPS dysfunction in the coated stent group while 22% of patients in the bare stent group had recurrence of portal hypertension related complications (p = 0.085). Actuarial probability of TIPS dysfunction in bare stents was 82% at 12 months compared to no episode in covered stent-grafts (p = 0.03). Mean increase in total serum bilirrubin was higher in the PTFE-coated stent group (6.7 mg/dl (14.4 mg/dl) versus 0.5 mg/dl (2.4 mg/dl), p = 0.01) without differences in encephalopathy nor mortality rate. Conclusion: One year shunt patency rate is improved with placement of ePTFE-covered stent-grafts without a higher rate of encephalopathy. Further prospective trials are required. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:120 / 124
页数:5
相关论文
共 25 条
[1]   Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results [J].
Angeloni, S ;
Merli, M ;
Salvatori, FM ;
De Santis, A ;
Fanelli, F ;
Pepino, D ;
Attili, AF ;
Rossi, P ;
Riggio, O .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (02) :280-285
[2]   Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents [J].
Angermayr, B ;
Cejna, M ;
Koenig, F ;
Karnel, F ;
Hackl, F ;
Gangl, A ;
Peck-Radosavljevic, M .
HEPATOLOGY, 2003, 38 (04) :1043-1050
[3]   Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS:: Results of a randomized study [J].
Bureau, C ;
Garcia-Pagan, JC ;
Otal, P ;
Pomier-Layrargues, G ;
Chabbert, V ;
Cortez, C ;
Perreault, P ;
Péron, JM ;
Abraldes, JG ;
Bouchard, L ;
Bilbao, JI ;
Bosch, J ;
Rousseau, H ;
Vinel, JP .
GASTROENTEROLOGY, 2004, 126 (02) :469-475
[4]   Segmental liver ischemia after TIPS procedure using a new PTFE-covered stent [J].
Bureau, C ;
Otal, P ;
Chabbert, V ;
Péron, JM ;
Rousseau, H ;
Vinel, JP .
HEPATOLOGY, 2002, 36 (06) :1554-1554
[5]  
BURROUGHS AK, 2000, PORTAL HYPERTENSION, V3, P13
[6]   Clinical events after transjugular intrahepatic portosystemic shunt:: Correlation with hemodynamic findings [J].
Casado, M ;
Bosch, J ;
García-Pagán, JC ;
Bru, C ;
Bañares, R ;
Bandi, JC ;
Escorsell, A ;
Rodríguez-Láiz, JM ;
Gilabert, R ;
Feu, F ;
Schorlemer, C ;
Echenagusia, A ;
Rodés, J .
GASTROENTEROLOGY, 1998, 114 (06) :1296-1303
[7]   Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: Initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis [J].
Cejna, M ;
Peck-Radosavljevic, M ;
Thurnher, SA ;
Hittmair, K ;
Schoder, M ;
Lammer, J .
RADIOLOGY, 2001, 221 (02) :437-446
[8]   The effect of initial shunt outflow position on patency of transjugular intrahepatic portosystemic shunts [J].
Clark, TWI ;
Agarwal, R ;
Haskal, ZJ ;
Stavropoulos, SW .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2004, 15 (02) :147-152
[9]   TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis:: A randomized controlled trial [J].
Escorsell, A ;
Bañares, R ;
García-Pagán, JC ;
Gilabert, R ;
Moitinho, E ;
Piqueras, B ;
Bru, C ;
Echenagusia, A ;
Granados, A ;
Bosch, J .
HEPATOLOGY, 2002, 35 (02) :385-392
[10]  
GONZALEZ M, 2004, GASTROENTEROL HEP S1, V27, P84